BNP Paribas Financial Markets’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-4,558
| Closed | -$46K | – | 3450 |
|
|
2015
Q4 | $46K | Sell |
4,558
-627
| -12% | -$6.33K | ﹤0.01% | 2862 |
|
|
2015
Q3 | $70.5K | Buy |
5,185
+3,099
| +149% | +$42.1K | ﹤0.01% | 2626 |
|
|
2015
Q2 | $39.6K | Buy |
2,086
+1,393
| +201% | +$26.4K | ﹤0.01% | 2633 |
|
|
2015
Q1 | $18.1K | Buy |
+693
| New | +$18.1K | ﹤0.01% | 2412 |
|
|
2014
Q4 | – | Sell |
-1,771
| Closed | -$59.1K | – | 3342 |
|
|
2014
Q3 | $59.1K | Buy |
1,771
+1,719
| +3,306% | +$57.4K | ﹤0.01% | 2080 |
|
|
2014
Q2 | $1.67K | Buy |
+52
| New | +$1.67K | ﹤0.01% | 2727 |
|
|
2014
Q1 | – | Sell |
-373
| Closed | -$26.5K | – | 3490 |
|
|
2013
Q4 | $26.5K | Sell |
373
-7,989
| -96% | -$567K | ﹤0.01% | 1723 |
|
|
2013
Q3 | $717K | Sell |
8,362
-1,769
| -17% | -$152K | ﹤0.01% | 1128 |
|
|
2013
Q2 | $642K | Buy |
+10,131
| New | +$642K | ﹤0.01% | 1128 |
|